Abstract
Granulopoiesis growth factors (G-CSF) are irreplaceable in oncology and hemato-oncology. Their effect and safety in hematopoietic stem cell transplantation settings and in granulopoeis recovery in risky chemotherapy have been repeatedly demonstrated.
G-CSF biosimilar molecules demonstrate similar effectiveness and safety.